- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Precious Metals
U.S. Pharmaceuticals & Biotech Precious Metals
Results
136
0 new
Gold, Silver and Precious Metals companies ordered by Snowflake size.
136 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
EXAS | US$67.94 | -4.1% | -1.8% | US$12.5b | US$77.57 | PS4.8x | E70.9% | n/a | ||
XOMA | US$25.48 | -14.6% | 78.9% | US$305.6m | US$83.00 | PS19.6x | E74.3% | n/a | ||
TENX | US$3.45 | -4.7% | -85.1% | US$11.9m | US$18.50 | PB1.3x | E58.8% | n/a | ||
RGEN | US$147.18 | 1.0% | -8.1% | US$7.8b | US$193.82 | PS13.7x | E85.3% | n/a | ||
BGNE | US$212.53 | 7.0% | 15.4% | US$22.0b | US$274.14 | PS7.3x | E64.1% | n/a | ||
VRTX | US$463.15 | -3.1% | 31.4% | US$119.2b | US$509.82 | PS11.6x | E46.4% | n/a | ||
DERM | US$5.47 | 7.7% | 102.6% | US$112.3m | US$9.13 | PE134.5x | E26.1% | n/a | ||
EVAX | US$3.06 | -2.9% | -64.0% | US$15.8m | US$11.56 | PS61.4x | E63.5% | n/a | ||
VRNA | US$27.64 | -6.0% | 67.3% | US$2.3b | US$36.50 | PB13.3x | E63.2% | n/a | ||
ZLAB | US$22.60 | 7.2% | -5.8% | US$2.0b | US$48.26 | PS6.9x | E65.9% | n/a | ||
LEGN | US$46.85 | -7.8% | -30.4% | US$8.0b | US$82.98 | PS18.9x | E63.7% | n/a | ||
BPMC | US$89.06 | -2.1% | 74.4% | US$5.5b | US$127.35 | PS15.6x | E67.4% | n/a | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
STVN | US$20.82 | 4.8% | -29.6% | US$5.5b | US$26.99 | PE41.5x | E18.3% | 0.3% | ||
ACHV | US$4.44 | -2.6% | 3.3% | US$150.4m | US$15.43 | PB3.6x | E50.6% | n/a | ||
ATOS | US$1.39 | -4.8% | 84.1% | US$174.8m | US$5.50 | PB2.2x | E71.1% | n/a | ||
CTKB | US$5.20 | -1.7% | -14.2% | US$665.4m | US$8.70 | PS3.5x | E111.9% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
RYTM | US$51.13 | -6.3% | 121.1% | US$3.2b | US$59.30 | PS30.7x | E62.6% | n/a | ||
SVRA | US$4.24 | -8.6% | 12.2% | US$683.1m | US$10.79 | PB6.9x | E55.7% | n/a | ||
TARS | US$33.15 | -4.2% | 104.1% | US$1.2b | US$58.75 | PS15.1x | E64.8% | n/a | ||
FTRE | US$19.80 | -17.0% | -30.9% | US$1.7b | US$24.02 | PB1.2x | E75.0% | n/a | ||
AVDL | US$12.60 | -7.4% | n/a | US$1.2b | US$23.90 | PS12.7x | E62.2% | n/a | ||
NTRA | US$123.85 | -2.6% | 173.3% | US$15.5b | US$130.17 | PS11.3x | E70.5% | n/a |